Nat Methods:高大上技术可有效识别单个癌细胞中的DNA突变

2016-06-05 佚名 生物谷

自德克萨斯大学MD安德森癌症中心的研究人员开发了一种新型的计算机程序,其可以帮助有效鉴别出单一癌细胞中的DNA突变,该技术或许就可以帮助临床医生提高癌症诊断的准确率,当然也为开发新型的癌症个体化疗法提供思路。 当前的新一代测序技术可以测定数百万个细胞中的基因组,而这种名为Monovar方法的程序则可以对组织样本中的重要基因突变进行检测;Monovar技术的建立基于单细胞测序技术,单细胞测序技

自德克萨斯大学MD安德森癌症中心的研究人员开发了一种新型的计算机程序,其可以帮助有效鉴别出单一癌细胞中的DNA突变,该技术或许就可以帮助临床医生提高癌症诊断的准确率,当然也为开发新型的癌症个体化疗法提供思路。

当前的新一代测序技术可以测定数百万个细胞中的基因组,而这种名为Monovar方法的程序则可以对组织样本中的重要基因突变进行检测;Monovar技术的建立基于单细胞测序技术,单细胞测序技术不仅用于癌症研究,还用于神经生物学、微生物学及免疫学领域的研究,Monovar作为基于单细胞测序的新型技术可以对单个细胞中基因组进行全方位分析,而不是数百万个细胞。Monovar技术可以对细胞间的检测结果进行对比,并且以极高的准确率来筛选出细胞间的不同,并不像单细胞测序那样,Monovar技术可以发现非常轻微的DNA突变,比如单核苷酸多态性(SNVs),而这一技术将可有效改善特殊癌症的诊断效率及准确性。

基于系统性的分析,Monovar算法可以从多个单一细胞中提取出相关数据来寻找SNVs,并且为每一个细胞提供非常详细的遗传数据。对SNVs的准确检测对于病人的治疗和护理非常关键,因为SNVs会影响个体的患病过程以及对多种药物和疫苗的反应,这些分子突变对于开发个体化疗法起着决定性的作用。

研究者Ken Chen说道,Monovar技术可以分析大规模的数据并且处理不同的全基因组方案,因此其完全适用于多种类型的研究;利用该技术我们就可以在线检查自己,相比其它标准方法而言,Monovar技术在检测突变和遗传变异上具有更高的准确性。在利用大数据和统计学分析工具进行癌症领域研究方面这并不是第一次了,来自全世界的多个实验室都在收集大量的数据来揭示癌症发生的机制以及如何开发特异性的疗法进行治疗。

研究者希望未来可以进行更为深入的研究,基于对大量数据的分析结果来开发出多种癌症个体化疗法。

原始出处

Hamim Zafar, Yong Wang, Luay Nakhleh, Nicholas Navin & Ken Chen.Monovar: single-nucleotide variant detection in single cells.Nat Methods.2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1881085, encodeId=79ea1881085cf, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Aug 28 01:16:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895908, encodeId=314318959084b, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 23 11:16:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252098, encodeId=dee2125209861, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533760, encodeId=3f781533e6060, content=<a href='/topic/show?id=c6fa6133f0' target=_blank style='color:#2F92EE;'>#DNA突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6133, encryptionId=c6fa6133f0, topicName=DNA突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=563e12483985, createdName=marongnuan, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88756, encodeId=2f5088e5693, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:53:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88755, encodeId=54c888e5595, content=是这样啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:52:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88599, encodeId=c24588599ad, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:03:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
    2016-08-28 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1881085, encodeId=79ea1881085cf, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Aug 28 01:16:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895908, encodeId=314318959084b, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 23 11:16:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252098, encodeId=dee2125209861, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533760, encodeId=3f781533e6060, content=<a href='/topic/show?id=c6fa6133f0' target=_blank style='color:#2F92EE;'>#DNA突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6133, encryptionId=c6fa6133f0, topicName=DNA突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=563e12483985, createdName=marongnuan, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88756, encodeId=2f5088e5693, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:53:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88755, encodeId=54c888e5595, content=是这样啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:52:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88599, encodeId=c24588599ad, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:03:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
    2016-11-23 一闲
  3. [GetPortalCommentsPageByObjectIdResponse(id=1881085, encodeId=79ea1881085cf, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Aug 28 01:16:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895908, encodeId=314318959084b, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 23 11:16:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252098, encodeId=dee2125209861, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533760, encodeId=3f781533e6060, content=<a href='/topic/show?id=c6fa6133f0' target=_blank style='color:#2F92EE;'>#DNA突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6133, encryptionId=c6fa6133f0, topicName=DNA突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=563e12483985, createdName=marongnuan, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88756, encodeId=2f5088e5693, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:53:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88755, encodeId=54c888e5595, content=是这样啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:52:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88599, encodeId=c24588599ad, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:03:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
    2016-06-07 yxch36
  4. [GetPortalCommentsPageByObjectIdResponse(id=1881085, encodeId=79ea1881085cf, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Aug 28 01:16:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895908, encodeId=314318959084b, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 23 11:16:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252098, encodeId=dee2125209861, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533760, encodeId=3f781533e6060, content=<a href='/topic/show?id=c6fa6133f0' target=_blank style='color:#2F92EE;'>#DNA突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6133, encryptionId=c6fa6133f0, topicName=DNA突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=563e12483985, createdName=marongnuan, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88756, encodeId=2f5088e5693, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:53:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88755, encodeId=54c888e5595, content=是这样啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:52:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88599, encodeId=c24588599ad, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:03:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1881085, encodeId=79ea1881085cf, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Aug 28 01:16:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895908, encodeId=314318959084b, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 23 11:16:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252098, encodeId=dee2125209861, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533760, encodeId=3f781533e6060, content=<a href='/topic/show?id=c6fa6133f0' target=_blank style='color:#2F92EE;'>#DNA突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6133, encryptionId=c6fa6133f0, topicName=DNA突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=563e12483985, createdName=marongnuan, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88756, encodeId=2f5088e5693, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:53:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88755, encodeId=54c888e5595, content=是这样啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:52:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88599, encodeId=c24588599ad, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:03:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
    2016-06-06 milkshark

    值得学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1881085, encodeId=79ea1881085cf, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Aug 28 01:16:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895908, encodeId=314318959084b, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 23 11:16:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252098, encodeId=dee2125209861, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533760, encodeId=3f781533e6060, content=<a href='/topic/show?id=c6fa6133f0' target=_blank style='color:#2F92EE;'>#DNA突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6133, encryptionId=c6fa6133f0, topicName=DNA突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=563e12483985, createdName=marongnuan, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88756, encodeId=2f5088e5693, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:53:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88755, encodeId=54c888e5595, content=是这样啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:52:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88599, encodeId=c24588599ad, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:03:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
    2016-06-06 milkshark

    是这样啊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1881085, encodeId=79ea1881085cf, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Aug 28 01:16:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895908, encodeId=314318959084b, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 23 11:16:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252098, encodeId=dee2125209861, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533760, encodeId=3f781533e6060, content=<a href='/topic/show?id=c6fa6133f0' target=_blank style='color:#2F92EE;'>#DNA突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6133, encryptionId=c6fa6133f0, topicName=DNA突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=563e12483985, createdName=marongnuan, createdTime=Tue Jun 07 02:16:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88756, encodeId=2f5088e5693, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:53:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88755, encodeId=54c888e5595, content=是这样啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Jun 06 06:52:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88599, encodeId=c24588599ad, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:03:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
    2016-06-05 沉心多思

    不错的文章,多学习

    0

相关资讯

PNAS:KFL2调节NK细胞稳态,可能用于肿瘤治疗

研究人员发现了一种生物机制,让“调整”免疫系统以杀死癌细胞成为一种潜在可行的方法。

盘点:5月Nature杂志亮点研究看过来

时光总是过得那么快,5月份转眼就要结束了,那么本月Nature杂志又有哪些亮点研究值得一读呢?请随小编来一一学习。 【1】癌细胞系的重新评估 doi | 10.1038/nature1798 对癌细胞系的药物敏感性所做的大规模分析以前曾被报告产生了冲突的结论。这项分析利用独立生成的数据显示,如果在未来研究中能将关键实验和数据分析实践考虑进去的话,一致性是可以做到的。 【2】抗生素抗

PNAS:科学家改善自然杀伤细胞 准确狙杀癌细胞

图片摘自:mdcurrent.in 来自美国范德堡大学医学中心(Vanderbilt University Medical Center)的科学家近日通过研究发现了一种潜在的方法可以调节机体免疫系统杀灭癌细胞的能力,文章中研究人员在小鼠机体中发现了一种耐受性机制,该机制可以抑制机体自然杀伤细胞(NK细胞)的能力,同时研究者还发现了一种可以克服该机制的潜在方法。 自然杀伤细胞是一种特殊类型的

Science:癌症免疫疗法重大突破,利用他人的T细胞抵抗癌症

在一项新的研究中,来自荷兰癌症研究所、挪威奥斯陆大学和丹麦哥本哈根大学的研究人员在癌症免疫疗法上取得新的突破,他们证实即便一个人自己的T细胞(一类免疫细胞)不能够识别和抵抗他们自身的肿瘤,但是其他人的T细胞可能会做到这点。相关研究结果于2016年5月19日在线发表在Science期刊上,论文标题为“Targeting of cancer neoantigens with donor-deriv

Development:惊人发现!靠近大脑的癌细胞竟然会高频率分裂恶化

图片来源:medicalxpress.com 近日,来自加利福尼亚大学的研究人员通过研究发现,当癌细胞越接近于大脑,其分裂越为频繁且更具“弹性”,这就揭示了癌细胞生长和神经系统之间的潜在关联。相关研究刊登于国际杂志Development上,该研究或为理解癌症的发病机制及开发新型疗法提供思路。 研究者Nestor J. Oviedo表示,目前我们正在寻找大脑或神经系统中哪一块特殊区域和癌症疯

Nature:揭示出增加癌细胞抵抗免疫攻击的PD-L1基因变异

在一项新的研究中,来自日本多家研究机构的研究人员针对成人T细胞白血病/淋巴瘤病例进行测序研究,结果发现一些癌细胞中的一些增加PD-L1蛋白产生的基因变异,这些基因变异增加癌细胞抵抗免疫系统攻击。相关研究结果近期发表在Nature期刊上,论文标题为“Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancer